Chart, page-2907

You're very correct in that this company is very innovative and I have no doubt they are already working on the next AI model for some other disease or condition. I admit 100% that I'm a pessimistic trader, regardless of what it is or whether I'm in it or not.
I constantly look for the smallest chink in the armor because when upsets happen it can affect the SP exponentially more so than even fantastic news.
So when I look at RHT I ask myself what could possibly go wrong?

1. Litigation over a bad patient outcome.
2. Litigation over IT property rights.
3. An unknown inherent flaw that has yet to be found and could take time/resources to overcome. Might even be tied into 1 or 2 above.
4. A breakdown of the clockwork perfect management and research team they've assembled.
5. Competition from foreign companies with lower market expectations.
6. Lack of, or exrtreme delay in, market acceptance.

Because RHT is an absolute fledgling company with such a low MC, any of these things could be catastrophic to their success.
For a penny stock company I believe that RHT is about as good as it can get. I have great faith in their long term abilities, but with that said, they are still a penny stock company and that alone puts them into a category of very high risk.

I have to use an abundance of caution when talking about this mob because the fundamentals of their company are so well put down, it's easy for me to "cheer" them on. I'm usually a harsh critic of any stock I'm in.

This is only my opinion and you should always do your own research.. and eat your vegetables too.. (since I'm stating the obvious)